Article
Role of prostate cancer stem-like cells in the development of antiandrogen resistance
1 Jan 2022
Abstract excerpt
Androgen deprivation therapy (ADT) is the standard of care treatment for advance stage prostate cancer. Treatment with ADT develops resistance in multiple ways leading to the development of castration-resistant prostate cancer (CRPC). Present research establishes that prostate cancer stem-like cells (CSCs) play a central role in the development of treatment resistance followed by disease progression. Prostate...
Topics
Join the communities discussing this publication.